##  [Novartis announces Tabrecta® first published overall survival and updated overall response data in patients with METex14 metastatic NSCLC](/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc-0 "Novartis announces Tabrecta® first published overall survival and updated overall response data in patients with METex14 metastatic NSCLC") 

  Jun 04, 2021